Literature DB >> 16744010

Chemical constitution and toxicity.

E Walker1.   

Abstract

Entities:  

Year:  1928        PMID： 16744010      PMCID： PMC1252117          DOI： 10.1042/bj0220292

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  1 in total

1.  The substances needed for the growth of a pure culture of Colpidium colpoda.

Authors:  R A Peters
Journal:  J Physiol       Date:  1921-05-24       Impact factor: 5.182
  1 in total
  10 in total

1.  Clinical uses of 2,2-dimercaptopropanol (BAL); the systemic treatment of experimental arsenic poisoning (mapharsen, lewisite, phenyl arsenoxide) with BAL.

Authors:  H EAGLE; H J MAGNUSON; R FLEISCHMAN
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

2.  Substances thioloprives.

Authors:  Z M BACQ
Journal:  Experientia       Date:  1946-09-15

3.  An analysis of the inhibition of pyruvate oxidation by arsenicals in relation to the enzyme theory of vesication.

Authors:  R A Peters; H M Sinclair; R H Thompson
Journal:  Biochem J       Date:  1946       Impact factor: 3.857

4.  Observations on the relation between sulphydryl groups and pyruvate oxidation in brain tissue.

Authors:  R A Peters; R W Wakelin
Journal:  Biochem J       Date:  1946       Impact factor: 3.857

5.  Pharmacology and biochemical lesions.

Authors:  R A PETERS
Journal:  Proc R Soc Med       Date:  1948-11

6.  The action of sulphydryl inhibitors upon isocitric dehydrogenase with especial reference to the behaviour of some trivalent arsenicals.

Authors:  W D LOTSPEICH; R A PETERS
Journal:  Biochem J       Date:  1951-10       Impact factor: 3.857

7.  British anti-lewisite; dithiol compounds as antidotes for arsenic.

Authors:  L A STOCKEN; R H S THOMPSON
Journal:  Biochem J       Date:  1946-07       Impact factor: 3.857

8.  British anti-lewisite; arsenic derivatives of thiol proteins.

Authors:  L A STOCKEN; R H S THOMPSON
Journal:  Biochem J       Date:  1946-07       Impact factor: 3.857

9.  CLINICAL USES OF 2,3-DIMERCAPTOPROPANOL (BAL). VIII. THE EFFECT OF BAL ON THE EXCRETION OF ARSENIC IN ARSENICAL INTOXICATION.

Authors:  J A Luetscher; H Eagle; W T Longcope; E B Watson
Journal:  J Clin Invest       Date:  1946-07       Impact factor: 14.808

10.  Preparation and pharmacological properties of 4-hydroxymethyl-2-(3'-amino-4'-hydroxyphenyl)-1:3-dithia-2-arsacyclopentane (Mapharside-BAL compound).

Authors:  R A Peters; L A Stocken
Journal:  Biochem J       Date:  1947       Impact factor: 3.857
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.